With forecasted growth of more than 20 percent annually for the next five to ten years, a population of 1.3 billion people, and a 10-year State stimulus plan for the industry overall, the healthcare industry in China is a compelling investment opportunity. THI-China was established to identify and capitalize on this growth opportunity.
The Tullis Health Investors – China team is uniquely qualified for this purpose, combining extensive healthcare investing expertise from the U.S. with a strong local Chinese investing partner, Goldstone Investment Ltd., the private equity investment arm of CITIC Securities in China.